“Innovation” Bill dangerous and unnecessary

Published: 15 Oct 2015

The Access to Medical Treatments (Innovation) Bill is being debated in the House of Commons on 16th October. Read AvMA’s briefing on why the main thrust of this Bill is dangerous and unnecessary. Our view is shared by leading patients’, doctors’ and medico-legal organisations.

We urge all those who share our concerns to write to their MP.